IRIS
BOFFA, GIACOMO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.357
Totale 2.357
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.357
Totale 2.357
Salva come PNG Salva come JPEG
Città #
Genova 904
Genoa 623
Vado Ligure 494
Rapallo 332
Bordighera 4
Totale 2.357
Salva come PNG Salva come JPEG
Nome #
Intense immunosuppression followed by autologous haematopoietic stem cell transplantation as a therapeutic strategy in aggressive forms of multiple sclerosis 150
Different MRI patterns in MS worsening after stopping fingolimod 140
A two alternative forced choice method for assessing vibrotactile discrimination thresholds in the lower limb 127
Relationship between retinal inner nuclear layer, age, and disease activity in progressive MS 120
Treatment of multiple sclerosis with rituximab: A multicentric Italian-Swiss experience 117
Prevalence of disability improvement as a potential outcome for multiple sclerosis trials 112
Degree of microstructural changes within T1-SE versus T1-GE hypointense lesions in multiple sclerosis: relevance for the definition of “black holes” 111
Could arterial spin labelling perfusion imaging uncover the invisible in N-methyl-d-aspartate receptor encephalitis? 106
Two-way crossed cerebellar diaschisis in a clinically isolated syndrome suggestive of multiple sclerosis 82
Preserved brain functional plasticity after upper limb task-oriented rehabilitation in progressive multiple sclerosis 80
Impact of treatment on cellular immunophenotype in MS: A cross-sectional study 74
Impact of highly active immunotherapy on acute and chronic neuroinflammation in aggressive multiple sclerosis 71
Fingolimod and Dimethyl-Fumarate-Derived Lymphopenia is not Associated with Short-Term Treatment Response and Risk of Infections in a Real-Life MS Population 69
COVID-19 pandemic and mental distress in Multiple Sclerosis: implications for clinical management 64
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab 62
Severe disease activity in MS patients treated with cladribine after fingolimod withdrawal 61
Autologous hematopoietic stem cell transplantation following alemtuzumab therapy in aggressive multiple sclerosis: A report of three cases 59
The early effect of cladribrine versus fingolimod on clinical and MRI measures in relapsing remitting multiple sclerosis 51
Tailoring B cell depletion therapy in MS according to memory B cell monitoring 50
Clinical and radiological correlates of apathy in multiple sclerosis 47
Embracing resilience in multiple sclerosis: a new perspective from COVID-19 pandemic 47
In-vivo characterization of macro- and microstructural injury of the subventricular zone in relapsing-remitting and progressive multiple sclerosis 46
In vivo evidence of hippocampal dentate gyrus expansion in multiple sclerosis 46
Long-term clinical outcomes of hematopoietic stem cell transplantation in multiple sclerosis 45
Disease-Modifying Therapies and Coronavirus Disease 2019 Severity in Multiple Sclerosis 43
Menstrual cycle resumption and female fertility after autologous hematopoietic stem cell transplantation for multiple sclerosis 42
Relationship Between Retinal Layer Thickness and Disability Worsening in Relapsing-Remitting and Progressive Multiple Sclerosis 42
Predictors of Ocrelizumab Effectiveness in Patients with Multiple Sclerosis 41
Central vein sign and diffusion MRI differentiate microstructural features within white matter lesions of multiple sclerosis patients with comorbidities 37
Personalizing ocrelizumab treatment in Multiple Sclerosis: What can we learn from Sars-Cov2 pandemic? 35
Hematopoietic Stem Cell Transplantation in People With Active Secondary Progressive Multiple Sclerosis 33
What happens after fingolimod discontinuation? A multicentre real-life experience 32
Physical exercise moderates the effects of disability on depression in people with multiple sclerosis during the covid-19 outbreak 25
The effect of Cladribine and Fingolimod treatments on retinal atrophy 22
An aggressive form of MOGAD treated with aHSCT: A case report 22
Vaccinations in patients with multiple sclerosis: a real-world, single-center experience 21
null 20
A diffusion tensor magnetic resonance imaging study of paediatric patients with severe non-traumatic brain injury 18
Effect of ocrelizumab treatment on retinal atrophy: preliminary results from a single-center observational study 16
Fronto-temporal vulnerability to disconnection in paediatric moderate and severe traumatic brain injury 13
Ultra-high-field 7-T MRI in multiple sclerosis and other demyelinating diseases: from pathology to clinical practice 12
Positron Emission Tomography with [18F]-DPA-714 Unveils a Smoldering Component in Most Multiple Sclerosis Lesions which Drives Disease Progression 12
Multiparametric Characterization and Spatial Distribution of Different MS Lesion Phenotypes 12
Lesion phenotyping based on magnetic susceptibility in pediatric multiple sclerosis 9
HSCT for stiff person syndrome and myasthenia gravis 9
E200k familial creutzfeldt-jakob disease presenting with subacute multiple cranial neuropathy 7
Totale 2.460
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.440
article - articoli 12.202
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 38
Totale 24.680
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020208 0 0 0 0 0 0 43 29 46 51 26 13
2020/2021293 14 25 82 48 15 18 7 20 18 24 11 11
2021/2022250 13 4 7 19 8 21 3 59 22 39 12 43
2022/2023407 31 36 5 48 36 55 2 25 54 20 77 18
2023/2024513 20 34 11 53 33 91 120 20 20 23 29 59
2024/2025575 82 95 58 73 149 118 0 0 0 0 0 0
Totale 2.460